|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 654951-654975 of 2348609 (93945 Page(s) Totally)
<< < 26194 26195 26196 26197 26198 26199 26200 26201 26202 26203 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-07-03T03:33:56Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T06:11:22Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:32Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 臺大學術典藏 |
2018-09-10T15:22:34Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Huang, Chung-Feng; PEI-JER CHEN; Liu, Chun-Jen; Dai, Chia-Yen; CHEN-HUA LIU; DING-SHINN CHEN; Huang, Jee-Fu; Lin, Jou-Wei; TUNG-HUNG SU; JIA-HORNG KAO; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung |
| 臺大學術典藏 |
2021-05-24T07:20:33Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-03-09T01:47:35Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2021-03-09T01:47:35Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:34Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
CHEN-HUA LIU; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:58Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:40Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H; | Liu C.-J; | Huang C.-F; | Lin J.-W; | Dai C.-Y; | Liang C.-C; | Huang J.-F; | Hung P.-H; | Tsai H.-B; | Tsai M.-K; | Lee C.-Y; | Chen S.-I; | Yang S.-S; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Yu M.-L; | Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:23Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:33Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; CHUN-JEN LIU; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-07T06:05:52Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; CHIH-YUAN LEE; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 國立臺灣大學 |
2009 |
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
|
許景盛; 高嘉宏; HSU, CHING-SHENG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:23Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu C.-S.; JIA-HORNG KAO |
| 國立成功大學 |
2016-05 |
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
|
Chan, Henry L. Y.;Ahn, Sang Hoon;Chang, Ting-Tsung;Peng, Cheng-Yuan;Wong, David;Coffin, Carla S.;Lim, Seng Gee;Chen, Pei-Jer;Janssen, Harry L. A.;Marcellin, Patrick;Serfaty, Lawrence;Zeuzem, Stefan;Cohen, David;Critelli, Linda;Xu, Dong;Wind-Rotolo, Megan;Cooney, Elizabeth |
| 臺大學術典藏 |
2021-07-03T03:33:52Z |
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
|
Chan H.L.Y.;Ahn S.H.;Chang T.-T.;Peng C.-Y.;Wong D.;Coffin C.S.;Lim S.G.;Pei-Jer Chen;Janssen H.L.A.;Marcellin P.;Serfaty L.;Zeuzem S.;Cohen D.;Critelli L.;Xu D.;Wind-Rotolo M.;Cooney E.;Lira-B Study Team; Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team |
| 國立成功大學 |
2012-12 |
Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease
|
Chan, Henry Lik-Yuen; Ahn, Sang Hoon; Chang, Ting-Tsung; Peng, Cheng-Yuan; Wong, David K.; Coffin, Carla S.; Lim, Seng Gee; Chen, Pei-Jer; Janssen, Harry L.; Marcellin, Patrick; Serfaty, Lawrence; Zeuzem, Stefan; Hu, Wenhua; Critelli, Linda; Lopez-Talavera, Juan Carlos; Cooney, Elizabeth L. |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak, R.;Kawazoe, S.;Znoyko, O.;Assy, N.;Gadano, A.;Kao, J.-H.;Lee, K.-S.;Zwirtes, R.;Portsmouth, S.;Dong, Y.;Xu, D.;Kumada, H.;Srinivasan, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:09Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak R.; Kawazoe S.; Znoyko O.; Assy N.; Gadano A.; JIA-HORNG KAO; Lee K.-S.; Zwirtes R.; Portsmouth S.; Dong Y.; Xu D.; Kumada H.; Srinivasan S. |
| 臺大學術典藏 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H. |
Showing items 654951-654975 of 2348609 (93945 Page(s) Totally)
<< < 26194 26195 26196 26197 26198 26199 26200 26201 26202 26203 > >>
View [10|25|50] records per page
|
